Culture Biosciences
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
269 E Grand Ave, South San Francisco, Ca...Website
www.culturebiosciences.comRevenue
$20.3 MillionIndustry
About Culture Biosciences
Culture Biosciences Org Chart
Is Culture Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Culture Biosciences has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Culture Biosciences recently announced quarterly report
Check if Culture Biosciences has recently received funding, and reach out quickly before it becomes old news!
Check out if Culture Biosciences is spiking on competitors!
Product Launch: Get notified when Culture Biosciences launches new products
Culture Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Culture Biosciences
Website visits: Recent activity has been detected on your website
Click to see if Culture Biosciences had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Culture Biosciences as Masked Content
Find 2 more new buyers
Compare Similar Companies to Culture Biosciences
Compare insights from companies similar to Culture Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Culture Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Culture Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Culture Biosciences.
Culture Biosciences financials insights
Gather financial insights about Culture Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Other Financing Round
$5.5M
Series A
$15M
Debt
$586K
Series B
$80M
Culture Biosciences Tech Stack
A closer look at the technologies used by Culture Biosciences
Most Recent Scoops
Culture Biosciences News & Media
Culture Biosciences Announces Close of Series C Round to Accelerate Commercial Growth of Stratyx 250 and Console Platform
Culture Biosciences closed a Series C to scale Stratyx™ 250 and advance its AI-powered Console platform for biologics, cell therapy, and synthetic biology.Xcell Biosciences and Culture Biosciences Partner to Advance Cell Therapy Quality Through AI and Machine Learning
Xcellbio and Culture Biosciences partner to integrate AVATAR Foundry with Console, enabling real-time data, remote monitoring, and AI-driven optimization.Culture Biosciences unveils Stratyx™ 250, the first cloud-integrated, mobile bioreactor for cell culture process development
Stratyx™ 250 is an innovative new bioreactor system from Culture Biosciences that accelerates bioprocess development, reduces costs and provides real-time remote control and monitoring for teams working on applications ranging from cell line development to protein expression. SOUTH SAN...Welcoming Victor Bornsztejn as Senior Vice President of Commercial
SAN FRANCISCO, CALIFORNIA, UNITED STATES, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Culture Biosciences, a leader in cloud-connected bioprocessing technologies, is pleased to announce the appointment of Victor Bornsztejn as the company’s new Senior Vice President of Commercial.
Top Business Services Companies
Frequently Asked Questions Regarding Culture Biosciences
Culture Biosciences specializes in bioprocess development technology, offering cloud-integrated bioreactors for cell culture, such as the Stratyx 250. Their products and services prioritize flexibility and real-time data analysis, aimed at reducing time-to-market for applications in protein therapeutics, viral vectors, and synthetic biology. The co... Read More